Vaccine hypersensitivity

Immunology and Allergy Clinics of North America

Volumn 21, Issue 4, 2001, Pages 707-743

  Crockett, R E ^a   Lockey, R F ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; BACTERIAL ANTIGEN; CHICKENPOX VACCINE; CHLORTETRACYCLINE; CHOLERA VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; DIPLOID CELL VACCINE; GELATIN; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFANTRIX; INFLUENZA VACCINE; IPOL; JAPANESE ENCEPHALITIS VACCINE; LYME DISEASE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; NEOMYCIN; ORAL POLIOMYELITIS VACCINE; PNEU IMMUNE 23; PNEUMOCOCCUS VACCINE; POLYMYXIN B; RABIES VACCINE; STREPTOMYCIN; TETANUS TOXOID; THIOMERSAL; TYPHOID VACCINE; UNCLASSIFIED DRUG; VACCINE; YELLOW FEVER VACCINE;

ALLERGY; ANAPHYLAXIS; ANOREXIA; ARTHRITIS; ASEPTIC MENINGITIS; CONVULSION; ERYTHEMA MULTIFORME; FEVER; GUILLAIN BARRE SYNDROME; HUMAN; HYPERSENSITIVITY; IMMUNIZATION; IMMUNOTHERAPY; INFECTION; MONONEUROPATHY; MYOSITIS; ORCHITIS; PAIN; PRIORITY JOURNAL; RASH; REVIEW; SEIZURE; THROMBOCYTOPENIA; VOMITING;

EID: 0035209165     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Booster vaccination against diphtheria and tetanus in man. III: Comparison of three different vaccine formulations
2. Booster vaccination against diphtheria and tetanus in man. II: Comparison of calcium phosphate and aluminum hydroxide as adjuvants
3. Measles immunization in children with allergy to egg
4. Active and passive immunization
5. The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine
6. Vaccinating children with a history of serious reactions after vaccination or of egg allergy
7. Influenza vaccine testing in egg sensitive patients
8. Update: Expanded availability of thimerosal preservative-free hepatitis B vaccine
9. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS)
10. Thimerosal in vaccines - An interim report to clinicians
11. Severe hypersensitivity or intolerance reactions to measles vaccine in six children
12. Measles immunization in children with history of egg allergy
13. Egg hypersensitivity and measles-mumps rubella vaccine administration
14. Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination
15. Measles immunization (MI) in children with IgE-mediated egg allergy
16. Safety of measles immunization in children with IgE-mediated egg allergy
17. Adverse effects and fatalities associated with allergen immunotherapy
18. Measles, mumps, rubella immunization in egg-allergic children: A long lasting debate
19. Alternaria IgG precipitins and adverse reactions
20. Allergic reactions to MMR vaccines in egg and non-egg-sensitive children: A continuing controversy
21. Rabies prevention - United States, 1991: Recommendations of the Immunization Practices Advisory Committee (ACIP)
22. Safety of vaccines
23. Contact sensitivity to aluminum in a patient hyposensitized with aluminum precipitated grass pollen
24. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children
25. Total and IgE antibody levels following booster immunization with aluminum adsorbed and nonadsorbed tetanus toxoid in humans
26. Safety of measles vaccine in egg-sensitive individuals
27. Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines
28. Thimerosal allergy and vaccination reactions
29. Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization
30. Safe MMR vaccination despite neomycin allergy
31. Anaphylaxis (ANA) to tetanus toxoid (TT): IgE-mediated disease
32. The waiting period after allergen skin testing and immunotherapy
33. Hypersensitivity to tetanus toxoid
34. Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine
35. Injection-site granuloma due to aluminum
36. Neurological complications of immunization
37. Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: A nationwide prospective study
38. Reactions to aluminum and its salts
39. Merthiolate hypersensitivity and vaccination
40. Lack of adverse reactions to measles, mumps, and rubella vaccine in egg-allergic children
41. Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts
42. Adverse reaction to measles immunization
43. Vaccination of children following a previous hypotonic-hyporesponsive episode
44. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies
45. Safe administration of mumps-measles-rubella vaccine in egg-allergic children
46. Major adverse reactions to yeast-derived hepatitis B vaccines - A review
47. Adjuvants for human vaccines - Current status, problems and future prospects
48. Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein
49. Adverse reaction to the recombinant hepatitis B vaccine
50. Adverse reactions to tetanus toxoid
51. Safe administration of influenza vaccine to patients with egg allergy
52. Safe administration of the measles vaccine to children allergic to eggs
53. Safe immunization of allergic children against measles, mumps, and rubella
54. Use of live, attenuated measles virus vaccine in children allergic to egg protein
55. Live, attenuated measles vaccine: Its administration to children allergic to egg protein
56. The positivity of thimerosal in Greece
57. Safety of measles vaccine in egg-sensitive individuals
58. Raw egg allergy - A potential issue in vaccine allergy
59. The gelatin story
60. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin
61. Measles immunization in children with clinical reactions to egg protein
62. Adverse effects of allergen immunotherapy: Assessment and treatment
63. Guidelines for measles vaccination in egg-allergic children
64. Gelatin-containing diphtheria-tetanus-pertussis (DTP) vaccine causes sensitization to gelatin in the recipients
65. Gelatin-specific humoral and cellular immune responses in children with immediate- and non-immediate- type reactions to live measles, mumps, rubella, and varicella vaccines
66. MMR vaccine and neomycin allergy
67. MMR vaccine and allergy
68. Measles, mumps, rubella vaccine and allergy to egg
69. Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children
70. Fatalities from immunotherapy (IT) and skin testing (ST)
71. Acute laryngeal obstruction presumed secondary to thimerosal (merthiolate) delayed hypersensitivity
72. Systemic reactions during cutaneous testing for tetanus toxoid hypersensitivity
73. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminum-adsorbed and fluid DT-vaccines
74. The role of aluminum for adverse reactions and immunogenicity of diphtheria-tetanus booster vaccine
75. Early-onset reaction after measles vaccination
76. The safety of egg-containing vaccines for egg-allergic patients
77. Specific IgG to gelatin in children with systemic immediate- and nonimmediate-type reactions to measles, mumps and rubella vaccines
78. Change in gelatin content of vaccines associated with reduction in reports of allergic reactions
79. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids
80. Measles vaccine in egg-allergic children
81. Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion
82. Preventing harm from thimerosal in vaccines
83. H2 cells in immediate and non-immediate reactions to gelatin-containing vaccine
84. Systemic reactions to measles-mumps rubella vaccine skin testing
85. Survey of fatalities from skin testing and immunotherapy 1985-1989
86. Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids
87. Neomycin sensitivity and the MMR vaccine
88. IgE sensitization to gelatin: The probable role of gelatin containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines
89. Sensitization to gelatin in children with systemic non-immediate-type reactions to varicella vaccines
90. Cases of systemic immediate-type urticaria associated with acellular diphtheria-tetanus-pertussis vaccination
91. IgE-mediated systemic reactions to gelatin included in the varicella vaccine
92. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines
93. IgE antibody to gelatin in children with immediate type reactions to measles and mumps vaccines
94. Sensitization to thimerosal and previous vaccination
95. Nonorganic adverse reactions to aeroallergen immunotherapy
96. Aluminum hydroxide granulomas: Light and electron microscopic studies and x-ray microanalysis
97. Systemic reactions from allergen immunotherapy
98. Skin testing prior to measles vaccination for egg-sensitive patients
99. IgE and IgG antibodies to β-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine
100. Gelatin-induced T-cell activation in children with non-anaphylactic-type reactions to vaccines containing gelatin
101. Hyposensitizing therapy with standard antigenic extracts: An important source of thimerosal sensitization
102. Systemic reactions due to thimerosal
103. Repeat whole cell vaccinations should be avoided after hypotonic-hyporesponsive episodes
104. Measles, mumps, rubella vaccine administration in egg-sensitive children: Systemic reactions during vaccine desensitization
105. Granuloma formation in normal guinea pigs injected intradermally with aluminum and zirconium compounds
106. Serum sickness triggered by anaphylaxis: A complication of immunotherapy
107. Immediate reactions following live attenuated measles vaccine
108. Aluminum allergy
109. Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: Follow up study
110. Generalized eczema in an 18-month-old-boy due to phenoxyethanol in DTP vaccine
111. Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine
112. General immune practices
113. Efficacy study of a new albumin-free human diploid cell rabies vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patients
114. Brachial plexus neuropathy: Association with desensitizing antiallergy injections
115. Adverse effects of immunization: Is prevention possible?